Genmab A/S (GNMSF)
337.00
+9.30
(+2.84%)
USD |
OTCM |
Aug 25, 16:00
Genmab Market Cap : 20.12B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 20.12B |
| August 24, 2026 | 19.56B |
| August 21, 2026 | 20.12B |
| August 20, 2026 | 20.00B |
| August 19, 2026 | 19.10B |
| August 18, 2026 | 19.10B |
| August 17, 2026 | 19.10B |
| August 14, 2026 | 18.54B |
| August 13, 2026 | 18.54B |
| August 12, 2026 | 18.60B |
| August 11, 2026 | 18.60B |
| August 10, 2026 | 18.60B |
| August 07, 2026 | 18.60B |
| August 06, 2026 | 17.61B |
| August 05, 2026 | 17.31B |
| August 04, 2026 | 17.30B |
| August 03, 2026 | 17.31B |
| July 31, 2026 | 17.75B |
| July 30, 2026 | 17.75B |
| July 29, 2026 | 17.75B |
| July 28, 2026 | 17.75B |
| July 27, 2026 | 17.56B |
| July 24, 2026 | 16.85B |
| July 23, 2026 | 16.85B |
| July 22, 2026 | 16.85B |
| Date | Value |
|---|---|
| July 21, 2026 | 16.85B |
| July 20, 2026 | 16.85B |
| July 17, 2026 | 17.31B |
| July 16, 2026 | 17.55B |
| July 15, 2026 | 17.55B |
| July 14, 2026 | 17.55B |
| July 13, 2026 | 17.55B |
| July 10, 2026 | 16.93B |
| July 09, 2026 | 17.41B |
| July 08, 2026 | 17.73B |
| July 07, 2026 | 17.32B |
| July 06, 2026 | 17.32B |
| July 02, 2026 | 16.88B |
| July 01, 2026 | 16.88B |
| June 30, 2026 | 16.88B |
| June 29, 2026 | 16.08B |
| June 26, 2026 | 16.08B |
| June 25, 2026 | 16.08B |
| June 24, 2026 | 15.80B |
| June 23, 2026 | 15.80B |
| June 22, 2026 | 15.35B |
| June 18, 2026 | 15.30B |
| June 17, 2026 | 15.30B |
| June 16, 2026 | 15.28B |
| June 15, 2026 | 15.28B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 16.46B |
| Zealand Pharma A/S | 3.617B |
| Bavarian Nordic A/S | 2.570B |
| Evaxion AS | 27.52M |
| ACADIA Pharmaceuticals, Inc. | 5.063B |
Market Cap Related Metrics
| PE Ratio | 26.62 |
| PS Ratio | 5.199 |
| Price to Book Value | 3.377 |
| Price to Free Cash Flow | 24.11 |
| Price | 337.00 |
| Earnings Yield | 3.76% |
| Operating PE Ratio | 16.10 |
| Normalized PE Ratio | 21.82 |